Skip to main navigation
Skip to search
Skip to main content
Universidad del Rosario Home
English
Español
Search content at Universidad del Rosario
Home
Profiles
Research units
Research output
Projects
Press/Media
Datasets
Prizes
Activities
Impacts
Student theses
Subcutaneous abatacept in rheumatoid arthritis: A real-life experience
Juan Camilo Sarmiento-Monroy
, Luisa Parada-Arias
, Milena Rodríguez-López
,
Mónica Rodríguez-Jiménez
,
Nicolás Molano-González
, Adriana Rojas-Villarraga
, Rubén Darío Mantilla
Center for Autoimmune Diseases Research (CREA)
urosario
Research output
:
Contribution to Journal
›
Review article
›
peer-review
5
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Subcutaneous abatacept in rheumatoid arthritis: A real-life experience'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
2-median
12%
Abatacept
100%
ACR Criteria
12%
Activity Function
12%
Activity Impairment
12%
Adverse Events
12%
Anti-cyclic Citrullinated Peptide (anti-CCP)
50%
Antibody Concentration
25%
Baseline Characteristics
12%
Biological Disease-modifying Antirheumatic Drugs (bDMARDs)
12%
Colombia
12%
Concomitant Use
12%
Constitutional Symptoms
12%
Cox Proportional Hazards Model
25%
Curve-based
12%
Demographic Characteristics
12%
Disease Activity Score 28 (DAS28)
37%
Disease Duration
12%
Disease Pattern
12%
Drug Survival
37%
Drug Suspension
12%
Erosive Disease
12%
Female Gender
12%
Functional Impairment
12%
Good Safety
12%
Headache
12%
Lack of Response
12%
Linear Mixed Model
12%
Loss of Effectiveness
12%
Low Activity
12%
Median Time
12%
Methotrexate
12%
Monotherapy
12%
Nave
12%
Outpatient Center
12%
Patient Characteristics
12%
Physical Function
12%
Published Data
12%
R Software
12%
RAPID3
50%
Real-world Experience
100%
Retention Rate
12%
Retrospective Cohort Study
12%
Rheumatoid Arthritis
100%
Rheumatoid Arthritis Disease Activity
12%
Rheumatoid Arthritis Patients
12%
Rheumatoid Factor
25%
Rheumatology
25%
Route of Administration
12%
Safety Profile
12%
Seronegative Patients
12%
Seropositivity
12%
Statistical Analysis
12%
Statistical Significance
12%
Subcutaneous Administration
12%
Survival Curve
25%
Treatment Duration
12%
Medicine and Dentistry
Abatacept
100%
Adverse Event
12%
Anti-Citrullinated Protein Antibody
50%
Constitutional Symptoms
12%
DAS28
37%
Disability
12%
Disease Activity
12%
Disease Duration
12%
Disease-Modifying Antirheumatic Drug
12%
Diseases
25%
Functional Disease
12%
Headache
12%
Infection
12%
Inflammatory Arthritis
100%
Methotrexate
12%
Monotherapy
12%
Outpatient
12%
Personal Experience
100%
Proportional Hazards Model
25%
Retrospective Cohort Study
12%
Rheumatoid Arthritis
100%
Rheumatoid Factor
25%
Rheumatology
25%
Routine Assessment of Patient Index Data
50%
Subcutaneous Injection
12%
Pharmacology, Toxicology and Pharmaceutical Science
Abatacept
100%
Adverse Event
12%
Cohort Study
12%
Cyclic Citrullinated Peptide Antibody
50%
Disability
12%
Disease Activity
12%
Disease Duration
12%
Diseases
25%
Functional Disease
12%
Headache
12%
Infection
12%
Inflammatory Arthritis
100%
Methotrexate
12%
Monotherapy
12%
Rheumatoid Arthritis
100%
Rheumatoid Factor
25%
Route of Administration
12%
Subcutaneous Injection
12%